Abstract
Abstract This study aimed to investigate the effect of a novel oral somatostatin-14 (SS-14) DNA vaccine fused to tissue plasminogen activator (tPA) signal peptide and CpG adjuvant on goat lactation and milk composition. Ten female goats with two newborn kids each were randomly divided into the immunized group and negative control group; The novel oral somatostatin (SS) DNA vaccine (fused to tPA signal peptide and CpG adjuvant) and empty vector bacteria were orally administered to these groups, respectively, at weeks 0, 3, and 6 of the study period. Blood samples were collected before primary immunization and at weeks 6 and 9 after primary immunization. The specific anti-SS antibody titers in the immunized group were significantly higher than that in the negative control group (P
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
